Furthermore, patients without PD-L1, TMB-H or dMMR/MSI-H tumours in some cases also show exceedingly promising responses leading to the hypothesis that other biomarkers might provide more sufficient predictive value (Zhang et al. 2021). The gene discussed is CD274; the disease is neoplasm.